DeDora Capital Inc. Invests $324,000 in CME Group Inc. (NASDAQ:CME)

DeDora Capital Inc. purchased a new position in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,221 shares of the financial services provider's stock, valued at approximately $324,000.

Several other institutional investors also recently bought and sold shares of the business. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth $25,000. Cornerstone Planning Group LLC increased its position in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Alpine Bank Wealth Management acquired a new position in CME Group during the 1st quarter valued at about $32,000. Finally, Financial Gravity Asset Management Inc. acquired a new position in CME Group during the 1st quarter valued at about $32,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CME has been the topic of a number of recent analyst reports. Keefe, Bruyette & Woods boosted their price target on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research report on Thursday, April 24th. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the company an "outperform" rating in a report on Thursday. Citigroup boosted their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research report on Thursday, July 3rd. Royal Bank Of Canada reissued a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a research report on Thursday, April 3rd. Finally, UBS Group restated a "neutral" rating and set a $305.00 price target on shares of CME Group in a report on Thursday. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, CME Group presently has an average rating of "Hold" and a consensus price target of $261.93.

CME Group Price Performance

CME stock traded up $0.70 during trading on Thursday, hitting $277.18. The company had a trading volume of 2,698,316 shares, compared to its average volume of 2,389,225. The company has a fifty day moving average price of $276.31 and a two-hundred day moving average price of $261.54. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $99.88 billion, a P/E ratio of 27.89, a P/E/G ratio of 4.79 and a beta of 0.44. CME Group Inc. has a fifty-two week low of $193.25 and a fifty-two week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the prior year, the firm earned $2.56 EPS. The firm's quarterly revenue was up 10.4% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were given a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.80%. CME Group's dividend payout ratio (DPR) is 50.30%.

Insider Buying and Selling at CME Group

In related news, Director Phyllis M. Lockett sold 1,060 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director owned 3,108 shares in the company, valued at $863,651.04. This represents a 25.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dennis Suskind sold 1,000 shares of the company's stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the transaction, the director owned 2,915 shares in the company, valued at approximately $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,400 shares of company stock worth $3,152,410 over the last quarter. Corporate insiders own 0.30% of the company's stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.